PATENT CLAIM ANALYSIS

Application Number: 15757816
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-12
Patent Classification: ["514", "302000"]

Abstract:
The present invention relates to compounds of general formula I wherein the groups R, R 1 , R 2 , m and n are defined as in claim  1 , which have valuable pharmacological properties, in particular bind to the GPR40 receptor and modulate its activity. The compounds are suitable for treatment and prevention of diseases which can be influenced by this receptor, such as metabolic diseases, in particular diabetes type 2. Furthermore, the invention relates to novel intermediates, useful for the synthesis of compounds of formula I.

Claim (Index 4):
The compound according to  claim 1 , wherein\n R 1  is H, F, Cl, H 3 C\u2014, H 3 C\u2014H 2 C\u2014, F 3 C\u2014, NC\u2014, or H 3 CO\u2014; R 2  is H or F; m is 2 and n is 1; or a salt thereof.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 90.0
- Lexical Diversity: 1.70175
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15225038', '16484124', '15818790', '13803237', '15876237']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7960349231754564
- 35 USC 102 Novelty (BERT): 0.5520027338753583
- Combined Prediction Score: 0.7716317042454467
- Mean Citation Score: 390.195968
- Max Citation Score: 394.82303
- Similarity Product: 363.8832064357221

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test